𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

✍ Scribed by Saskia J. A. M. Santegoets; Marco W. J. Schreurs; Allan J. Masterson; Ying Poi Liu; Steffen Goletz; Hans Baumeister; Esther W. M. Kueter; Sinéad M. Lougheed; Alfons J. M. van den Eertwegh; Rik J. Scheper; Erik Hooijberg; Tanja D. de Gruijl


Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
391 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Tumor-specific CD8+ T lymphocytes derive
✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge

Identification of GP100-derived, melanom
✍ Ichiro Kawashima; Van Tsai; Scott Southwood; Kazutoh Takesako; Esteban Celis; Al 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 2 views

The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i

Induction of human leukocyte antigen (HL
✍ Kanaoka, Shunji; Yamasaki, Seiji; Okino, Takashi; Inoue, Naoya; Shimada, Yutaka; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Background and objectives: Using peripheral blood mononuclear cells (pbmcs) from a 10-year survivor with established human leukocyte antigen (hla)-a2(+) and mage-3(+) esophageal cancer cell line (kyse-170), we examined the induction of hla-a2-restricted and mage-3-gene-derived peptide (flwgpralv

CD80 expression in an HLA-A2-positive hu
✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix